AAAAAA
Results:
1-16
|
Results: 16
Authors:
Kataoka, A
Sadanaga, N
Mimori, K
Ueo, H
Barnard, GF
Sugimachi, K
Auclair, D
Chen, LB
Mori, M
Citation: A. Kataoka et al., Overexpression of HRad17 mRNA in human breast cancer: Correlation with lymph node metastasis, CLIN CANC R, 7(9), 2001, pp. 2815-2820
Authors:
Etoh, T
Ueo, H
Inoue, H
Sato, K
Utsunomiya, T
Barnard, GF
Kitano, S
Mori, M
Citation: T. Etoh et al., Clinical significance of K-ras mutations in intraoperative tumor drainage blood from patients with colorectal carcinoma, ANN SURG O, 8(5), 2001, pp. 407-412
Authors:
Inoue, H
Mimori, K
Utsunomiya, T
Sadanagaa, N
Barnard, GF
Ueo, H
Mori, M
Citation: H. Inoue et al., Heparanase expression in clinical digestive malignancies, ONCOL REP, 8(3), 2001, pp. 539-542
Authors:
Mimori, K
Ueo, H
Shirasaka, C
Mori, M
Citation: K. Mimori et al., Clinical significance of MT1-MMP mRNA expression in breast cancer, ONCOL REP, 8(2), 2001, pp. 401-403
Authors:
Mimori, K
Inoue, H
Alder, H
Ueo, H
Tanaka, Y
Mori, M
Citation: K. Mimori et al., Mutation analysis of hBUB1, human mitotic checkpoint gene in multiple carcinomas, ONCOL REP, 8(1), 2001, pp. 39-42
Authors:
Tanaka, S
Ueo, H
Mafune, KI
Mori, M
Wands, JR
Sugimachi, K
Citation: S. Tanaka et al., A novel isoform of human fibroblast growth factor 8 is induced by androgens and associated with progression of esophageal carcinoma, DIG DIS SCI, 46(5), 2001, pp. 1016-1021
Authors:
Inoue, H
Mimori, K
Shiraishi, T
Kataoka, A
Sadanaga, N
Ueo, H
Barnard, GF
Mori, M
Citation: H. Inoue et al., Expression of tissue inhibitor of matrix metalloproteinase-1 in human breast carcinoma, ONCOL REP, 7(4), 2000, pp. 871-874
Authors:
Kataoka, A
Mori, M
Sadanaga, N
Ueo, H
Tsuji, K
Rai, Y
Barnard, GF
Sugimachi, K
Citation: A. Kataoka et al., RT-PCR detection of breast cancer cells in sentinel lymph modes, INT J ONCOL, 16(6), 2000, pp. 1147-1152
Authors:
Matsuyama, Y
Tominaga, T
Nomura, Y
Koyama, H
Kimura, M
Sano, M
Miura, S
Takashima, S
Mitsuyama, S
Ueo, H
Ohashi, Y
Citation: Y. Matsuyama et al., Second cancers after adjuvant tamoxifen therapy for breast cancer in Japan, ANN ONCOL, 11(12), 2000, pp. 1537-1543
Authors:
Shibuta, K
Inoue, H
Sato, K
Matsuyama, A
Ueo, H
Tanaka, Y
Mafune, K
Barnard, GF
Mori, M
Citation: K. Shibuta et al., L-myc restriction fragment length polymorphism in Japanese patients with esophageal cancer, JPN J CANC, 91(2), 2000, pp. 199-203
Authors:
Mori, M
Mimori, K
Sadanaga, N
Inoue, H
Tanaka, Y
Mafune, KI
Ueo, H
Barnard, GF
Citation: M. Mori et al., Prognostic impact of tissue inhibitor of matrix metalloproteinase-1 in esophageal carcinoma, INT J CANC, 88(4), 2000, pp. 575-578
Authors:
Mimori, K
Ueo, H
Shirasaka, C
Shiraishi, T
Yamagata, M
Haraguchi, R
Mori, M
Citation: K. Mimori et al., Up-regulated pyrimidine nucleoside phosphorylase in breast carcinoma correlates with lymph node metastasis, ANN ONCOL, 10(1), 1999, pp. 111-113
Authors:
Fujie, T
Tanaka, F
Tahara, K
Li, J
Tanaka, S
Mori, M
Ueo, H
Takesako, K
Akiyoshi, T
Citation: T. Fujie et al., Generation of specific antitumor reactivity by the stimulation of spleen cells from gastric cancer patients with MAGE-3 synthetic peptide, CANCER IMMU, 48(4), 1999, pp. 189-194
Authors:
Hasegawa, H
Ueo, H
Nanbara, S
Tsuji, K
Mori, M
Akiyoshi, T
Citation: H. Hasegawa et al., An effective pre-operative chemoimmunotherapy regimen against advanced gallbladder carcinoma: A case report, HEP-GASTRO, 46(27), 1999, pp. 1639-1642
Authors:
Yamagata, M
Mori, M
Mimori, K
Mafune, KI
Tanaka, Y
Ueo, H
Akiyoshi, T
Citation: M. Yamagata et al., Expression of pyrimidine nucleoside phosphorylase mRNA plays an important role in the prognosis of patients with oesophageal cancer, BR J CANC, 79(3-4), 1999, pp. 565-569
Authors:
Mori, M
Shiraishi, T
Tanaka, S
Yamagata, M
Mafune, K
Tanaka, Y
Ueo, H
Barnard, GF
Sugimachi, K
Citation: M. Mori et al., Lack of DMBT1 expression in oesophageal, gastric and colon cancers, BR J CANC, 79(2), 1999, pp. 211-213
Risultati:
1-16
|